SEC Form 4 research

Hemab Therapeutics Holdings, Inc. insider transactions

Issuer	Hemab Therapeutics Holdings, Inc.
Tickers	COAG
Reporting owners	21
Officers and directors	2
Last public filing	2026-09-25

Recent insider disclosures

Available	Trade date	Reporting owners	Code	Shares	Price	Reported value
2026-09-25	2026-09-24	Walbert Keli	A	36,000	$0	Not reported

Officers and directors in the directory

RA Capital Nexus Fund II, L.P. — 86 qualifying
Kolchinsky Peter — 1,083 qualifying
RA Capital Healthcare Fund LP — 1,055 qualifying
RA CAPITAL MANAGEMENT, L.P. — 1,081 qualifying
RA Capital Nexus Fund IV, L.P. — 6 qualifying
Shah Rajeev M. — 388 qualifying

Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.